Doctor profile · Federal record
Dr. Deirdre Reid-Fighera, M.D.
Rheumatology Physician (CMS: Rheumatology) · Meadowbrook, PA
- NPI 1841220662
- Accepts Medicare
- MIPS 96.3 / 100 · 2023
- 26 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1650 Huntingdon Pike, Suite 352
Meadowbrook, PA 190468004
(267) 571-2151
fax (215) 379-8387
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- July 6, 2016
- Year of graduation
- 2000 — 26 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Pennsylvania #MD428826
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1841220662. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
20,818
Distinct HCPCS
10
Medicare allowed
$778,006
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 7,950 | 13 | $42 | |
J0897 |
Injection, denosumab, 1 mg | 6,240 | 71 | $23 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 4,790 | 11 | $31 | |
96372 |
Injection of drug or substance under skin or into muscle | 345 | 90 | $15 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 343 | 185 | $134 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 179 | 44 | $69 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 176 | 30 | $137 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 144 | 123 | $95 | |
J3489 |
Injection, zoledronic acid, 1 mg | 130 | 26 | $9 | |
96415 |
Administration of chemotherapy into vein, each additional hour | 126 | 17 | $29 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 1,040. This provider delivers 20× the peer median.Open Payments
Industry payments received
All-time total
$209
Transactions
10
Manufacturers
5
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $72.59 | |
| Amgen Inc. | 3 | $61.27 | |
| Janssen Biotech, Inc. | 1 | $39.94 | |
| UCB, Inc. | 1 | $17.84 | |
| Sandoz Inc. | 1 | $17.28 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,792
Patients
464
Total drug cost
$816,263
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate | Generic | 395 | 99 | $18,635 |
| Prednisone | Generic | 252 | 73 | $4,469 |
| Methotrexate (Methotrexate Sodium) | Brand | 205 | 49 | $8,116 |
| Gabapentin | Generic | 117 | 32 | $2,946 |
| Methylprednisolone | Generic | 109 | 62 | $2,023 |
| Alendronate Sodium | Generic | 97 | 22 | $783 |
| Enbrel Sureclick (Etanercept) | Brand | 90 | 0 | $761,616 |
| Sulfasalazine | Generic | 90 | 21 | $2,317 |
| Duloxetine Hcl | Generic | 86 | 26 | $3,128 |
| Meloxicam | Generic | 63 | 26 | $377 |
Frequently asked questions
What is Dr. Deirdre Reid-Fighera's medical specialty?
Dr. Deirdre Reid-Fighera practices Rheumatology Physician in Meadowbrook, PA.
Where does Dr. Deirdre Reid-Fighera practice?
Dr. Deirdre Reid-Fighera practices at 1650 Huntingdon Pike, Meadowbrook, PA 190468004. Office phone: 2675712151.
What is Dr. Deirdre Reid-Fighera's NPI?
Dr. Deirdre Reid-Fighera's National Provider Identifier (NPI) is 1841220662, issued by NPPES.
Does Dr. Deirdre Reid-Fighera accept Medicare assignment?
Yes. Dr. Deirdre Reid-Fighera accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Deirdre Reid-Fighera commonly perform?
Top Medicare-reported procedures in 2023: Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, denosumab, 1 mg (HCPCS J0897); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745). Source: CMS Medicare Physician & Other Practitioners file.